Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled trial of elobixibat in chronic idiopathic constipation
2012-005587-94Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of elobixibat in functional constipation (FC) (3 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Overall complete spontaneous bowel movement response. Started Mar 2013; status: completed.
02
Drugs
elobixibat
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on 2012-005587-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005587-94.